Cargando…

Abnormalities of signal transduction networks in chronic schizophrenia

Schizophrenia is a serious neuropsychiatric disorder characterized by disruptions of brain cell metabolism, microstructure, and neurotransmission. All of these processes require coordination of multiple kinase-mediated signaling events. We hypothesize that imbalances in kinase activity propagate thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGuire, Jennifer L., Depasquale, Erica A., Funk, Adam J., O’Donnovan, Sinead M., Hasselfeld, Kathryn, Marwaha, Shruti, Hammond, John H., Hartounian, Vahram, Meador-Woodruff, James H., Meller, Jarek, McCullumsmith, Robert E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595970/ https://www.ncbi.nlm.nih.gov/pubmed/28900113 http://dx.doi.org/10.1038/s41537-017-0032-6

Ejemplares similares

Ampa Receptor Subunit Expression in the Endoplasmic Reticulum in Frontal Cortex of Elderly Patients with Schizophrenia
por: Hammond, John C., et al.
Publicado: (2012)

32.2 ABNORMALITIES OF SYNAPTIC PROTEOMES IN SCHIZOPHRENIA
por: Funk, Adam, et al.
Publicado: (2018)

F201. KINASE NETWORK DYSREGULATION IN SCHIZOPHRENIA: IMPLICATIONS FOR NEW TREATMENT STRATEGIES
por: Bentea, Eduard, et al.
Publicado: (2018)

Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia
por: O'Donovan, S M, et al.
Publicado: (2015)

Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity
por: Wu, Xiaojun, et al.
Publicado: (2021)

KRSA: An R package and R Shiny web application for an end-to-end upstream kinase analysis of kinome array data
por: DePasquale, Erica A. K., et al.
Publicado: (2021)

S183. ABNORMALITIES IN SERINE/THREONINE SIGNALING NETWORKS IN SEVERE NEUROPSYCHIATRIC ILLNESS: DEVELOPMENT OF A PIPELINE TO EXPLORE ABNORMALITIES OF KINASE ACTIVITY AND IDENTIFY NOVEL TREATMENT STRATEGIES FOR SCHIZOPHRENIA
por: McCullumsmith, Robert, et al.
Publicado: (2020)

Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2018)

Protein expression of prenyltransferase subunits in postmortem schizophrenia dorsolateral prefrontal cortex
por: Pinner, Anita L., et al.
Publicado: (2020)

Decreased Chloride Channel Expression in the Dorsolateral Prefrontal Cortex in Schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2015)

Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
por: Imami, Ali S., et al.
Publicado: (2021)

12.2 METABOLIC CONSEQUENCES OF DEVELOPMENTAL NMDA RECEPTOR HYPOFUNCTION
por: Funk, Adam, et al.
Publicado: (2018)

12.1 CELL-SUBTYPE SPECIFIC BIOENERGETIC DEFECTS IN SCHIZOPHRENIA
por: Sullivan, Courtney, et al.
Publicado: (2018)

The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
por: O’Donovan, Sinead M., et al.
Publicado: (2017)

Deficits in pattern separation and dentate gyrus proliferation after rodent lateral fluid percussion injury
por: Correll, Erika A., et al.
Publicado: (2021)

Disclosing the potential impact of placebo controls in antidepressant trials
por: Chen, Stephanie C., et al.
Publicado: (2015)

Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS
por: O’Donovan, Sinead M, et al.
Publicado: (2020)

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
por: Creeden, Justin Fortune, et al.
Publicado: (2021)

Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
por: O’Donovan, Sinead M., et al.
Publicado: (2021)

Using protein turnover to expand the applications of transcriptomics
por: Smail, Marissa A., et al.
Publicado: (2021)

Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
por: Hamoud, Abdul-Rizaq, et al.
Publicado: (2022)

32.1 MECHANISMS OF ABNORMAL POSTTRANSLATIONAL PROTEIN PROCESSING IN SCHIZOPHRENIA BRAIN
por: Meador-Woodruff, James
Publicado: (2018)

SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
por: Meikle, Claire Kyung Sun, et al.
Publicado: (2021)

Measurement of lactate levels in postmortem brain, iPSCs, and animal models of schizophrenia
por: Sullivan, Courtney R., et al.
Publicado: (2019)

Corticostriatal dysfunction and social interaction deficits in mice lacking the cystine/glutamate antiporter
por: Bentea, Eduard, et al.
Publicado: (2020)

Altered purinergic receptor expression in the frontal cortex in schizophrenia
por: Alnafisah, Rawan, et al.
Publicado: (2022)

F202. ABNORMAL REMODELING PROCESSING IN NEURAL GPI-APS SECRETORY PATHWAY IN SCHIZOPHRENIA
por: Kim, Pitna, et al.
Publicado: (2018)

Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments
por: Rubio, Maria D., et al.
Publicado: (2012)

Abnormal subcellular localization of GABA(A) receptor subunits in schizophrenia brain
por: Mueller, T M, et al.
Publicado: (2015)

Abnormal ER quality control of neural GPI-anchored proteins via dysfunction in ER export processing in the frontal cortex of elderly subjects with schizophrenia
por: Kim, Pitna, et al.
Publicado: (2019)

Gene Enrichment Analysis of Astrocyte Subtypes in Psychiatric Disorders and Psychotropic Medication Datasets
por: Zhang, Xiaolu, et al.
Publicado: (2022)

Subcellular partitioning of protein kinase activity revealed by functional kinome profiling
por: Wegman-Points, Lauren, et al.
Publicado: (2022)

Activation of acid‐sensing ion channels by carbon dioxide regulates amygdala synaptic protein degradation in memory reconsolidation
por: Lin, Boren, et al.
Publicado: (2021)

Similarities and dissimilarities between psychiatric cluster disorders
por: Smail, Marissa A., et al.
Publicado: (2021)

Intracellular compartment-specific proteasome dysfunction in postmortem cortex in schizophrenia subjects
por: Scott, Madeline R., et al.
Publicado: (2019)

Post-translational protein modifications in schizophrenia
por: Mueller, Toni M., et al.
Publicado: (2020)

UQlust: combining profile hashing with linear-time ranking for efficient clustering and analysis of big macromolecular data
por: Adamczak, Rafal, et al.
Publicado: (2016)

S192. AKT-MTOR SIGNALING PATHWAY IS DOWNREGULATED IN SCHIZOPHRENIA
por: Chadha, Radhika, et al.
Publicado: (2018)

T181. PROTEIN ACYL-THIOESTERASE ENZYME ACTIVITY IN THE POSTMORTEM DORSOLATERAL PREFRONTAL CORTEX IN SCHIZOPHRENIA
por: Hopper, Shaun, et al.
Publicado: (2020)

Kinome Array Profiling of Patient-Derived Pancreatic Ductal Adenocarcinoma Identifies Differentially Active Protein Tyrosine Kinases
por: Creeden, Justin F., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2emjlnp7tdka21vhhver07mc4p